News
Market and company headlines
PLURAll
Loading
03:00Yesterday1 Story
04:00-09:00Oct 212 Stories
Pluri Chairman and Active Investor Alejandro Weinstein to Acquire EIB Loan, in Strong Vote of Confidence in the Company
Chairman-led transaction marks the first step in a broader series of actions to provide a more flexible framework to support the Company's commercial plansHAIFA, Israel, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq, TASE: PLUR) (“Pluri” or the “Company”), a biotechnology company advancing cell-based solutions in regenerative medicine and longevity, today announced that Alejandro Weinstein, Chairman of the Board and the largest shareholder of the Company, has entered into an agreement to
Pluri To Sell EIB Loan To Its Chairman And Largest Shareholder Alejandro Weinstein, Who Will Replace The EIB As Lender
Upon completion of the transaction, Mr. Weinstein will replace the EIB as lender under the existing loan arrangements and will succeed to all of the lender’s rights and remedies thereunder, as in effect at the time of
03:00-08:00Oct 132 Stories
Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat Productivity
Collaboration Demonstrates Substantially Higher Protein and Biomanufacturing Productivity While Producing Structured Cultivated TissueHAIFA, Israel and EDINBURGH, Scotland, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Ever After Foods (EAF) and Roslin Technologies today announced results from their joint cultivated meat production program. Combining Roslin Technologies' advanced cell platform with Ever After Foods' proprietary Edible Packed Bed (EPB™) technology, the companies demonstrated substantial gain
Pluri's Ever After Foods, Roslin Technologies Report Major Gains In Cultivated Meat Output
Ever After Foods (EAF) and Roslin Technologies today announced results from their joint cultivated meat production program. Combining Roslin Technologies' advanced cell platform with Ever After Foods'
04:00Sep 181 Story
04:00-09:00Aug 272 Stories
Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor
HAIFA, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri”), a biotechnology company, leveraging its proprietary three-dimensional ("3D") cell expansion platform across two principal business verticals: (i) Human Health & Longevity and (ii) FoodTech & Bio-Farming, today announced that it has entered into a securities purchase agreement with a single healthcare focused institutional investor, for the purchase and sale of 2,228,940 Common Shares (or Common Sha
Pluri Commences ~$3.3M Offering Of 2.229M Common Shares At $1.50 Per Share
Pluri Inc. (NASDAQ:PLUR) (TASE: PLUR) ("Pluri"), a biotechnology company, leveraging its proprietary three-dimensional ("3D") cell expansion platform across two principal business verticals: (i) Human